[HTML][HTML] MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4

J Lin, L Zhang, H Huang, Y Huang, L Huang, J Wang… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Abstract Karyopherin alpha 2 (KPNA2) is a nuclear transport protein upregulated in many
cancers. Our previous study has identified KPNA2 overexpression in epithelial ovarian …

[HTML][HTML] Screening and prognostic value of potential biomarkers for ovarian cancer

H Li, M Li, C Tang, L Xu - Annals of translational medicine, 2021 - ncbi.nlm.nih.gov
Background Ovarian cancer is a common gynecological malignant tumor that greatly
threatens women's health, so we screened potential biomarkers of ovarian cancer and …

POLD2 and KSP37 (FGFBP2) Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas

BV Elgaaen, KBF Haug, J Wang, OK Olstad… - PloS one, 2010 - journals.plos.org
Background Epithelial ovarian cancer (EOC) constitutes more than 90% of ovarian cancers
and is associated with high mortality. EOC comprises a heterogeneous group of tumours …

LncRNA KCNQ1OT1 accelerates ovarian cancer progression via miR-125b-5p/CD147 axis

P Chen, LS Sun, HM Shen, B Qu - Pathology-Research and Practice, 2022 - Elsevier
Background Ovarian cancer (OC) is one of the most common gynecological malignancies
with a high incidence. Researches showed that lncRNA KCNQ1OT1 (KCNQ1OT1) was …

miR-21 induces chemoresistance in ovarian cancer cells via mediating the expression and interaction of CD44v6 and P-gp

Y Wang, G Chen, F Dai, L Zhang, M Yuan… - OncoTargets and …, 2021 - Taylor & Francis
Background Ovarian cancer (OC), a representative female reproductive system tumor, is one
of the most malignant tumors in female. The most important reason for its poor prognosis is …

[HTML][HTML] CDC20 is a novel biomarker for improved clinical predictions in epithelial ovarian cancer

X Xi, T Cao, Y Qian, H Wang, S Ju, Y Chen… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Epithelial ovarian cancer (EOC), a common tumor of the female reproductive system, ranks
first in fatalities among gynecological malignancies. Most patients find tumors at late stage …

Identification of the hub genes associated with the prognosis of ovarian cancer patients via integrated bioinformatics analysis and experimental validation

Y Zhao, J Pi, L Liu, W Yan, S Ma… - Cancer Management and …, 2021 - Taylor & Francis
Background This study aimed to identify the hub genes associated with prognosis of patients
with ovarian cancer by using integrated bioinformatics analysis and experimental validation …

Identification and validation of a gene-based signature reveals SLC25A10 as a novel prognostic indicator for patients with ovarian cancer

Q Li, J Wang, J Jiang, B Lin - Journal of Ovarian Research, 2022 - Springer
Background Ovarian cancer is a common gynecological cancer with poor prognosis and
poses a serious threat to woman life and health. In this study, we aimed to establish a …

Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics

C Dong, X Tian, F He, J Zhang, X Cui, Q He… - Journal of ovarian …, 2021 - Springer
Background Ovarian cancer is one of the most common gynecological tumors, and among
gynecological tumors, its incidence and mortality rates are fairly high. However, the …

MiR-126-3p inhibits ovarian cancer proliferation and invasion via targeting PLXNB2

G Xiang, Y Cheng - Reproductive biology, 2018 - Elsevier
Ovarian cancer is one of the leading malignancies in women and the 5-year survival rate of
ovarian cancer still remains poor. In the present study, we aimed to investigate the …